IL6 and neoplasm: The up-regulation of these markers is associated with the activation of the NF-kB pathway, which influences tumor growth and metastasis via increases in TNF-α and activation of STAT3 (activator of transcription) pathways increasing cell proliferation via IL-6 production (92), all contributors to poor prognosis (93, 94).